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Abstract
Background: The different treatment strategies for bone cysts in children are often associated with persistence
and high recurrence rates of the lesions. The safety and clinical outcomes of a combined mechanical and
biological treatment with elastic intramedullary nailing, artificial bone substitute and autologous platelet rich
plasma are evaluated.
Methods: From 02/07 to 01/09 we offered all children with bone cysts the treatment combination of elastic
intramedullary nailing (ESIN), artificial bone substitute (Orthoss
®) and autologous platelet rich plasma, concentrated
by the Gravitational Platelet Separation (GPS
®) - System. All patients were reviewed radiologically for one year
following the removal of the intramedullary nailing, which was possible because of cyst obliteration.
Results: A cohort of 12 children (4 girls, 8 boys) was recruited. The mean patient age was 11.4 years (range
7-15 years). The bone defects (ten humeral, two femoral) included eight juvenile and four aneurysmal bone cysts.
Five patients suffered from persistent cysts following earlier unsuccessful treatment of humeral bone cyst after
pathologic fracture; the other seven presented with acute pathologic fractures. No peri- or postoperative
complications occurred. The radiographic findings showed a total resolution of the cysts in ten cases (Capanna
Grade 1); in two cases a small residual cyst remained (Capanna Grade 2). The intramedullary nails were removed six
to twelve months (mean 7.7) after the operation; in one case, a fourteen year old boy (Capanna Grade 2), required
a further application of GPS
® and Orthoss
® to reach a total resolution of the cyst. At follow-up (20-41 months,
mean 31.8 months) all patients showed very good functional results and had returned to sporting activity. No
refracture occurred, no further procedure was necessary.
Conclusions: The combination of elastic intramedullary nailing, artificial bone substitute and autologous platelet
rich plasma (GPS
®) enhances the treatment of bone cysts in children, with no resulting complications.
Background
Juvenile bone cysts were first described by Virchow in
1876, but their aetiology still remains unknown [1].
They can occur in any bone, most often in the long
bones and at any age, but mainly in the first two dec-
ades [2]. Despite their benign nature, simple bone cysts
interfere with everyday activities. This is because the
cysts weaken the cortex, predisposing the bone to
pathological fracture. Various treatment options have
been reported apart from the principle of ‘watch and
wait’ for spontaneous consolidation. The filling of the
cysts with cortisone [3-6], bone marrow [7-9] or allo-
genic bone grafts [10-12] have been described. Another
approach is to stabilize the cyst with elastic stable intra-
medullary nails, allowing for immediate mobilization.
This procedure can also be combined with a bone sub-
stitute [13,14] or the decompression of the cyst with
cannulated screws [15]. However, none of these treat-
ments has been evaluated as being superior to the
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any medium, provided the original work is properly cited.others in terms of avoiding the persistence of the condi-
tion, recurrence or refractures [2,16].
In the case of a fracture, a healing process is initiated
with fibrin clot formation, platelet aggregation and
degranulation. Platelets contain numerous growth fac-
tors such as platelet-derived growth factor, transforming
growth factor beta, insulin-like growth factors I and II
and epidermal growth factor [17-19]. Experimental stu-
dies have shown that a gravitational platelet-separating
system is able to boost the concentration of growth fac-
tors. This has the potential to stimulate the prematurely
terminated bone-healing processes, especially when
combined with autologous bone or bone graft materials
[20-22]. Initial published studies on the use of autolo-
gous concentrated platelets in poorly healing dermal
wounds [23,24] and in artificial joint surgery [25] have
also demonstrated its efficiency.
Nowadays in our dynamic and sportive society, chil-
dren and adolescents want to return to all activities as
soon as possible and are afraid of refractures of the
cysts arising from minor trauma. Driven by our own
mediocre results during the treatment of juvenile bone
cysts with prednisolone, cannulated “decompression”
screws or ESIN in isolation, we looked for an alternative
additional treatment strategy to hasten healing and to
minimize the need for repeat operations. This study
evaluates the safety and clinical outcome of the treat-
ment with elastic intramedullary nailing (ESIN), artificial
bone substitute (Orthoss
®) and autologous platelet rich
plasma (GPS
®) in bone cysts in children.
Methods
From February 2007 to January 2009 we offered a com-
bined treatment to all children with bone cysts who had
suffered a pathologic fracture or the failure of earlier treat-
ment. The treatment combination consisted of elastic
intramedullary nailing (two ascending Titanium Nails, dia-
meter depending on the medullar canal between 2.0 an
3.0 mm, Fa. Santech Nord, Germany), curettage, artificial
bone substitute (Orthoss
®, Fa. Geistlich, Germany) and
autologous platelet rich plasma (GPS
®,B i o m e tM e r c kB i o -
materials, Berlin, Germany). Orthoss
® is an inorganic
bone matrix with a macro- and microporous structure
derived from bovine material. With the interconnecting
pore structure and high inner surface it is an osteoconduc-
tive matrix, which is structurally integrated into the sur-
rounding bone and incorporated into the physiological
remodeling process. It is indicated for the filling of bone
voids following trauma, for reconstruction in orthopedics
and in spinal surgery [26-28]. The material has been in
use for more than 20 years and more than 4 million appli-
cations are documented [29]. This new treatment combi-
nation was carried out with the informed consent of the
parents and the patients themselves.
For each subject in the study, the following data are
presented: age, gender, location and histology of cyst,
earlier treatment history, peri- and postoperative morbid-
ity and further operative procedures. Prior to operation,
the distal-proximal, medial-lateral and anterior-posterior
extent of every cyst was digitally determined from plain
X-ray images.
Patients taking medicines known to influence platelet
function or patients who had a platelet count < 100/nl
were excluded from the study.
The autologous platelet rich plasma was augmented by
the commercially available GPS
®-System [30,31]. A blood
sample of 40 to 110 ml was taken from each of the
patients during anesthesia. The volume taken depended
on the size of the cyst and the age of the patient. The pre-
paration of GPS
® was performed in the operating theatre
during the actual surgical intervention and took 20 min-
utes. In this procedure the blood was separated into three
basic components: red blood cells, platelet poor plasma
and 10-20 ml platelet-rich plasma (Figure 1).
Surgery was always performed under general anesthe-
sia. After reduction of the fracture the elastic intrame-
dullary nailing (ESIN) was performed under fluoroscopic
guidance in an ascending matter (2-C-configuration).
The diameter of the nails (2.0 to 3.0 mm) was selected
on the basis of the preoperative anterior-posterior radio-
graph (digitally measured). In the cases of failed earlier
treatment, elastic intramedullary nails were removed
first. The production of GPS did not require any length-
ening of the operation or the time of anesthesia, as it
was carried out simultaneously. In all cases the bone
cysts were then opened in a minimally invasive manner
by an approximately 2 cm long incision. A small speci-
men for histological investigation was taken and the cyst
debrided. Afterwards the 10 to 20 ml GPS
® (platelet
rich plasma) was mixed with the artificial bone substi-
tute (Orthoss
®) and the cyst filled up with this mixture
as completely as possible. The treatment protocol
involved no further immobilization following intracuta-
neous wound closure.
All patients were reviewed with clinical examination,
X-rays and functional evaluation four weeks after the
operation, then every three months until complete bone
mineralization occurred and removal of the nails was possi-
ble. Because long-term results were unknown we arranged
one further visit one year after the nails were removed.
Treatment results were classified according to the
scheme used by Capanna:
- Grade 1 = healed - the cyst was completely filled in
with bone and the cortical margin thickened
- Grade 2 = healed with residual cyst - the cyst was
consolidated with bone and the cortical margin
thickened but there were still residual cyst parts
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Page 2 of 12- Grade 3 = recurrence - the cyst initially consoli-
dated with bone, but large areas of osteolysis and
cortical thinning subsequently recurred
- Grade 4 = no response - the cyst showed no evi-
dence of response to the treatment [4].
Grades 1 and 2 were defined as success, whereas
grades 3 and 4 represented a failure in treatment. Statis-
tical analysis was descriptive: averages and ranges were
determined. Because the expected number of subjects
was below twenty, no statistical tests were performed.
Ethics
The study confirmed to the Helsinki Declaration and
was approved by the local ethics committee of the Uni-
versity of Luebeck [AZ 10-223].
Results
Study participations
A cohort of twelve children (four girls, eight boys) was
recruited. Mean patient age was 11.4 years (range
7-15 years) at the time of surgery. Histologically the
bone defects included eight juvenile and four aneurys-
mal bone cysts (Table 1).
Five patients had suffered prior unsuccessful treatment of
humeral bone cyst after pathologic fracture with intrame-
dullary nailing and curettage (Figures 2, 3, 4 and 5) or artifi-
cial bone substitution in one case; the other seven presented
with acute pathologic fractures (five humeral, two femoral;
Figures 6, 7, 8 and 9). They all received the treatment com-
bination of elastic intramedullary nailing (ESIN), artificial
bone substitute (Orthoss
®) and autologous platelet rich
plasma (GPS
®). None satisfied the exclusion criteria.
Two further patients (one boy, one girl) refused to parti-
cipate. The pathologic fractures of these patients were sta-
bilized with ESIN alone. Another patient excluded from
this study presented with a 30 mm × 40 mm × 50 mm
sized cyst of the calcaneus. After debridement, the defect
was filled with Orthoss
® and GPS
®. X-rays after 3 and 6
months showed complete mineralization of the former cyst.
Peri-and postoperative morbidity
No side effects were obvious before and after the admis-
sion of ESIN, Orthoss
® and GPS
®. No postoperative com-
plications such as infection, deviation of axis, re-operation
of intramedullary nailing or refractures occurred.
Follow up
At the first outpatient visit, four weeks after the opera-
tion, all patients reported complete pain relief from an
average time of one week after the surgery. The time
Figure 1 GPS
®-Tube after centrifugation.T h eG P S
® tube after
centrifugation: The red blood cells fraction at the bottom of the
tube is separated from the buffy coat by a buoy. The platelet-rich
plasma is above and is separated from the platelet-poor plasma
after the white plunger is manually pushed down.
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Page 3 of 12taken for the patients to return to full, unrestricted
activities was four to six weeks. The radiological findings
at four weeks showed the beginning of fracture healing
and mineralization of the defect. After three months no
deviation of axis was evident and radiological examina-
tion revealed that the cysts had begun to heal.
The radiological findings at six month showed a total
resolution of the cysts in ten cases (Capanna Grade 1);
in two cases a small residual cyst remained (Capanna
Grade 2). All fractures healed and complete bone miner-
alization had occurred. The tiny residual cysts remained
on the proximal end of the cyst. The patients with and
without a residual cyst had identical treatment strategy.
In the two cases with residual cysts, the intraoperative
X-rays clearly revealed a technical error: an incomplete
filling of these parts of the cysts (Figures 10, 11 and 12).
The intramedullary nailing was removed five to twelve
months after the operation (mean 7.7 months); in one
case a fourteen year old boy (Capanna Grade 2) wished
af u r t h e rG P S
® and Orthoss
® application to reach a
total resolution. All patients are still being followed up
(20-41 months, mean 31.8 months), they show good
functional results without any movement limitations and
no refracture occurred after they returned to sports.
Discussion
T h eq u e s t i o na st ow h e t h e rac o n s e r v a t i v eo ro p e r a t i v e
treatment is the best treatment strategy in unicameral
bone cysts, has been an active one since the Neer’s
observational series of about 175 cases. Children and
adolescents with bone cysts often present first with
pathologic fractures. While gross dislocation calls for
reduction and stabilization, immobilization can be the
treatment of choice for cases with little dislocation or in
cysts detected by chance. However, one or more refrac-
tures are known to occur in around ten percent of all
children [16]. These complications are the reason why
children limit their normal physical activities, which
inhibits their social development. In the longer term, all
lesions in younger children show high persistence and
recurrence rates following conservative treatment. In the
proximal humerus and femur - the most frequent locali-
zations - the prognosis following both treatment options
was reported to be less satisfactory. As a consequence,
Table 1 Clinical characteristics of the study population
Age Sex Cyst
type *
Cyst
Location
Cyst Size (mm)** Acute
Fracture
Prior treatment and Complication Time to nail
removal
(month)
Follow-up
(month)
Outcome
Grade
(Capanna)
1 10.4 f JBC Humerus
proximal
47 × 12 × 14 + - 7 41 2
2 11.8 f ABC Humerus
proximal
39 × 19 × 15 - ESIN + (Cerasorb
®) for 3.5 years, nail
exchange twice, Valgus, Capanna 4
73 9 1
3 13.3 m JBC Humerus
central
75 × 23 × 17 - ESIN alone, 2.5 years, Capanna 4 12*** 37 2
4 15.5 m ABC Femur
distal
65 × 22 × 14 + - 6 36 1
5 11.0 m JBC Humerus
proximal
66 × 13 × 22 - ESIN alone > 4 years, nail exchange
three times, Capanna 3
12 34 1
6 9.9 m JBC Humerus
central
57 × 20 × 19 + - 5 32 1
7 12.5 f JBC Humerus
proximal
40 × 27 × 15 + - 11 31 1
8 15.3 f ABC Humerus
proximal
50 × 23 × 23 - ESIN alone, > 2.5 years, Capanna 4 7 30 1
9 14.0 m ABC Humerus
proximal
62 × 24 × 20 + - 8 28 1
10 9.3 m JBC Femur
proximal
36 × 29 × 18 + - 8 28 1
11 9.7 m JBC Humerus
proximal
55 × 19 × 18 - ESIN alone > 3 years, nail exchange
once, Capanna 3
4.5 25 1
12 7.0 m JBC Humerus
proximal
48 × 18 × 19 + - 5 20 1
*JBC = Juvenile bone cyst; ABC = Aneurysmal bone cyst.
**To estimate the size of the defects, every cyst was digitally measured from the plain X-rays in mm prior to operation: distal-proximal, medial-lateral and
anterior-posterior.
***One 14 year old boy wished a further GPS
® and Orthoss
® application at the age of 14 years because of a small residual cyst (6 ml) and complicated prior
treatment with ESIN alone.
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Page 4 of 12NEER supported prompt surgical intervention with cur-
ettage and bone grafting as “the best way to rehabilitate
these young children” producing successful healing in
55% to 65% of cases [32].
Other treatment strategies such as filling the cysts
with cortisone [3,5,6], bone marrow [7-9,33,34] or allo-
g e n i cb o n eg r a f t sw e r ee v a l u a t e d[ 1 0 - 1 2 , 3 5 ] .L o n g - t e r m
studies of percutaneous injection of methylprednisolone
acetate have not supported the initial satisfactory results
with success rates of only about 50 to 60% [36]. Failure
rates of about 80% for cortisone, 64% for curettage and
50% of combined procedures with bone marrow have
been reported [16]. In a case series Lokiec reported the
consolidation of bone cysts in all ten patients treated
with percutaneous autologous marrow grafting allied to
multiple perforations of the cysts before injection [33],
which - in our opinion - will additionally weaken the
affected bone. All these described methods may produce
Figure 2 Failed Consolidation after treatment with nailing
alone. Persistence of cyst after earlier failed treatment (Elastic stable
intramedullary Nailing 4 years previously).
Figure 3 Failed Consolidation after treatment with nailing
alone. Elastic stable intramedullary Nailing in combination with
Orthoss
® and GPS
® after earlier failed treatment. Radiograph three
months following the initial GPS
®/Orthoss
® treatment resulting in
bone mineralization.
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Page 5 of 12Figure 4 Complete Consolidation after a long history of failed
treatment. Valgus deformity of the humerus after failed earlier
treatment of juvenile bone cyst with Elastic stable intramedullary
Nails and a different artificial bone substitute. After 3 years of failed
treatment the result was classified as Capanna Grade 4. During
removal of the nails and the combined treatment with ESIN-
osteosynthesis, Orthoss
® and GPS
® an additional external fixation
was needed due to instability. The Fixateur was removed after 4
weeks, the nails after 6 months.
Figure 5 Complete Consolidation after a long history of failed
treatment. Results 13 months after ESIN and treatment with
Orthoss
® and GPS
®. Clinically the patient achieved an excellent
functional result without refracture or deviation of axis.
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Page 6 of 12consolidation of the cyst but they do not initially
enhance the mechanical stability of the weakened bone
[37]. As a consequence patients have to avoid strenuous
activities and sports for the duration of the healing pro-
cess, which might be years [6,16]. In our experience,
this is not seen as a valid therapeutic option by parents
and patients.
Mechanical stability was achieved by the improvement
in pediatric surgery with elastic intramedullary nailing of
the pathologic fractures. It is described as a minimal
invasive surgery, which supports the healing of the cysts.
Stabilization of the bone allows early mobilization of the
patients without major complications [14,37]. The disad-
vantage is the moderate success rates of about 70% for
complete healing and the prolonged healing period,
necessitating the exchange of the elastic stable nails
once or twice during therapy [14]. In two of our patients
the removal of the nails was really difficult and one
further patient experienced an unsuccessful attempt to
remove the nails in another hospital. The difficult chan-
ging operations and concomitant prolonged periods of
Figure 6 Patient presenting with acute pathologic fracture.
Consolidation with ESIN, Orthoss
® and GPS
®. Pathologic fracture of
the right humerus after a fall on wet grass.
Figure 7 Patient presenting with acute pathologic fracture.
Consolidation with ESIN, Orthoss
® and GPS
®. Lateral view X-ray five
months after treatment with ESIN, Orthoss
® and GPS
®.A sa
consequence, Nails could be removed.
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Page 7 of 12Figure 8 Patient presenting with acute pathologic fracture.
Consolidation with ESIN, Orthoss
® and GPS
®. Anterior-posterior
X-ray five months after treatment with ESIN, Orthoss
® and GPS
®.
As a consequence, Nails could be removed.
Figure 9 Patient presenting with acute pathologic fracture.
Consolidation with ESIN, Orthoss
® and GPS
®. 12 months after nail
removal. Capanna Typ 1.
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Page 8 of 12postoperative immobilization render this method uncon-
vincing [13,38]. In our study earlier treatment with ESIN
on its own had failed in four patients, which was also
the case in another cyst that was additionally treated
with a product containing tricalciumphosphate (Cera-
sorb
®). The duration of their treatment history was four
years and two of the children underwent multiple
operations.
The combined biological and mechanical treatment of
simple bone cysts was described for the first time by
Kanellopoulos. His treatment employed demineralized
bone matrix and autologous bone marrow injection in
addition to intramedullary nailing for the stabilization of
bone cysts. In seven patients the cysts consolidated
completely; two consolidated partially [13,38]. Although
autologous bone marrow collection is considered a rela-
tively simple procedure, it can be associated with
numerous complications such as biopsy site bleeding,
hematoma or infection [39,40]. Harvesting enough bone
marrow for huge cysts in children is sometimes proble-
matic and causes more pain than filling the cyst and
implanting the nails. To avoid these complications, we
added GPS
® and Orthoss
® to our treatment, the ratio-
nale being that the application of growth factors from
the platelet-rich plasma has been shown to promote tis-
sue repair in many other clinical situations such as cra-
nio-facial surgery [41].
With the combined mechanical and biological treat-
ment of elastic intramedullary nailing, artificial bone
substitute and autologous platelet rich plasma, we
describe an option having the possibility of early
removal of the intramedullary nailing (six to twelve
months, mean 7.7 month), thus avoiding changing
operations. In our patients it prevented further patholo-
gic fractures and was able to avoid long-lasting limita-
tions in activity. Our approach lead to visible (2 - 3 cm)
scars on the upper arm or the leg and two further small
incisions for the nails, but the children were satisfied
Figure 10 Incomplete filling of the cyst. Acute pathologic
fracture of the right proximal humerus.
Figure 11 Incomplete filling of the cyst.I n t r a o p e r a t i v e
fluoroscopic control after Orthoss
® and GPS
® application. Small
filling defect in the upper part of the former cyst visible.
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Page 9 of 12with their appearance. No patient showed any changes
i nt h e i ri n t r a -o rp o s t o p e r a tive vital parameters. The
most significant benefits of using the GPS
®-System are
its autologous nature, the fact that it is endogenously
derived and its easy availability. There are no issues of
immunogenicity or transmission of infection by using
the GPS
®-System or the artificial bone substitute
Orthoss
®. Hass reported the successful use of deminera-
lized human bone matrix (Grafton
®) for the treatment
of bone cysts in seven children. The disadvantages of
this approach are the high costs and the, albeit low, risk
of infection [42].
Another interesting study from 2010 published data
on 24 patients treated with ChronOS
® (Synthes, Swit-
zerland). Treatment with this new synthetic tricalcium-
phosphate cement resulted in successful healing of
different bony lesions in 19 cases; in two others healing
with residual cyst. During follow-up from one to twenty
months ten defects were observed with partial or subto-
tal absorption of the injected cement. The volume
injected ranged from 2-30 ml [43].
In our series the radiographic evaluation showed com-
plete healing in 10 of 12 patients; only two patients had
a small residual cyst in the upper part of the earlier cyst.
Apart from one patient, no X-rays were performed later
than three years after removal of the implant, because
cysts are known not to recur once totally consolidated
after treatment [3]. Rougraff demonstrated, that most
cyst recurrence occurred at their proximal or distal ends
and suggested that this might be related to incomplete
filling of the end of the cysts [11]. Retrospective analysis
of all X-rays from the intraoperative fluoroscopic films
confirmed that the filling of the upper part of the cyst
was incomplete in our 2 cases with small residual cysts.
In all patients the removal of the nails was possible after
only six to twelve months (mean 7.7 month); such short
treatment period has never been previously reported in
the literature. Rougraff showed radiographically, that by
six to nine months, mature cortical thickening was present
in most of his patients, and it was seen in almost every
patient by one year. He confirmed that the radiographic
features changed very little after one year following treat-
ment [11]. From our data we can conclude that the combi-
nation with Orthoss
® and GPS
® will fasten the healing of
the cysts.
Two years after the combined treatment strategy with
elastic intramedullary nailing (ESIN), artificial bone sub-
stitute (Orthoss
®) and autologous platelet rich plasma
(GPS
®) our preliminary results are promising, but further
prospective studies are necessary to validate the efficacy.
Although this is a small series that lacks a control group,
Figure 12 Incomplete filling of the cyst.2 3m o n t h sa f t e rn a i l
removal. Small residual cyst in the area of the former postoperative
defect (Capanna Typ 2).
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Page 10 of 12the results were excellent with no mayor complications
such as re-fracture or re-operation (apart from possible
early implant removal). The time to healing was short
and the children returned early to full daily activities,
having suffered restrictions for no more than one month.
At the latest examination more than one year after
implant removal there was no clinical evidence of cyst
recurrence and the functional results were optimal.
In our opinion, our promising results as well as the
results of the treatment with Grafton
® [42] and
ChronOS
® [43] justify a prospective multicenter study
for further evaluation.
Conclusions
The combination of elastic intramedullary nailing, artifi-
cial bone substitute (Orthoss
®) and autologous platelet
rich plasma (GPS
®-System) enhances the treatment of
bone cysts in children. It is a safe method without addi-
tional perioperative complications and it shortened total
treatment time in our series compared to earlier strate-
gies. Secondary procedures such as difficult removal of
the elastic stable intramedullary nails followed by a new
implantation as well as re-do surgery due to refractures
or deviation of axis were avoided. Technically the deci-
sive factor is the debridement of the cyst with the com-
plete filling of the cyst with artificial bone substitute and
autologous platelet rich plasma to avoid residual cysts.
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